From the University of Connecticut School of Nursing, Storrs, CT.
University of Connecticut Department of Statistics, Storrs, CT.
Pediatr Emerg Care. 2024 Apr 1;40(4):283-288. doi: 10.1097/PEC.0000000000003023. Epub 2023 Aug 7.
Penicillin or amoxicillin are the recommended treatments for the most common pediatric bacterial illnesses. Allergies to penicillin are commonly reported among children but rarely true. We evaluated the impact of reported penicillin allergies on broad-spectrum antibiotic use overall and for the treatment of common respiratory infections among treat-and-release pediatric emergency department (ED) visits.
Retrospective cohort study of pediatric patients receiving antibiotics during a treat-and-release visit at a large, pediatric ED in the northeast from 2014 to 2016. Study exposure was a reported allergy to penicillin in the electronic medical record. Study outcomes were the selection of broad-spectrum antibiotics and alternative (second-line) antibiotic therapy for the treatment of acute otitis media (AOM) and group A streptococcus (GAS) pharyngitis. We used unadjusted and adjusted generalized estimating equation models to analyze the impact of reported penicillin allergies on the selection of broad-spectrum antibiotics. We used unadjusted and adjusted logistic regression models to determine the probability of children with a documented penicillin allergy receiving alternative antibiotic treatments for AOM and GAS.
Among 12,987 pediatric patients, 810 (6.2%) had a documented penicillin allergy. Penicillin allergies increased the odds of children receiving a broad spectrum versus narrow spectrum antibiotic (adjusted odds ratio, 13.55; 95% confidence interval (CI), 11.34-16.18). In our adjusted logistic regression model, the probability of children with a documented penicillin allergy receiving alternative antibiotic treatment for AOM was 0.97 (95% CI, 0.94-0.99) and for GAS was 0.97 (95% CI, 0.92-0.99).
Antibiotic stewardship efforts in pediatric EDs may consider the delabeling of penicillin allergies particularly among children receiving antibiotics for an acute respiratory infection as a target for intervention.
青霉素或阿莫西林是治疗最常见儿科细菌病的推荐治疗方法。儿童中常报告对青霉素过敏,但很少是真正的过敏。我们评估了报告的青霉素过敏对广谱抗生素总体使用以及治疗和释放儿科急诊部(ED)就诊中常见呼吸道感染的治疗的影响。
回顾性队列研究,研究对象为 2014 年至 2016 年期间在东北部一家大型儿科 ED 接受治疗和释放就诊时接受抗生素治疗的儿科患者。研究暴露是电子病历中报告的对青霉素过敏。研究结果是急性中耳炎(AOM)和 A 组链球菌(GAS)咽炎治疗中广谱抗生素的选择和替代(二线)抗生素治疗。我们使用未经调整和调整后的广义估计方程模型分析报告的青霉素过敏对广谱抗生素选择的影响。我们使用未经调整和调整后的逻辑回归模型来确定有记录的青霉素过敏儿童接受 AOM 和 GAS 替代抗生素治疗的可能性。
在 12987 名儿科患者中,810 名(6.2%)有记录的青霉素过敏。青霉素过敏使儿童接受广谱抗生素而非窄谱抗生素的可能性增加(调整后的优势比,13.55;95%置信区间(CI),11.34-16.18)。在我们调整后的逻辑回归模型中,有记录的青霉素过敏儿童接受 AOM 替代抗生素治疗的概率为 0.97(95%CI,0.94-0.99),GAS 为 0.97(95%CI,0.92-0.99)。
儿科 ED 的抗生素管理工作可能会考虑取消特别是接受急性呼吸道感染抗生素治疗的儿童的青霉素过敏标签,作为干预的目标。